By Josh Beckerman
WeTrade Group Inc. shares were recently down 24% to $10.75 and have had an intraday range of $10.50 to $24.90.
The Beijing-based company’s operations include a software-as-a-service, such as the YCloud system.
Last week, WeTrade announced a partnership with Jiqing Biomedical Technology Co. focused on sales channels for monkeypox test kits and antigen tests.
Write to Josh Beckerman at josh.beckerman@wsj.com
Read the full article here
